Institute for Medical Microbiology and Epidemiology of Infectious Diseases, University Hospital of Leipzig, Liebigstraße 21, 04103 Leipzig, Germany.
Institute for Medical Microbiology and Epidemiology of Infectious Diseases, University Hospital of Leipzig, Liebigstraße 21, 04103 Leipzig, Germany.
J Glob Antimicrob Resist. 2021 Mar;24:328-334. doi: 10.1016/j.jgar.2021.01.007. Epub 2021 Jan 27.
Bacteroides spp. are normal constituents of the human intestinal microflora, but they are also able to cause severe diseases. The aim of this study was to determine the diversity of antibiotic resistance genes found in phenotypically resistant Bacteroides and Parabacteroides strains.
A total of 71 phenotypically resistant Bacteroides spp. from human clinical specimens were screened for the antibiotic resistance genes cfiA, tetQ, tetM, tet36, cepA, cfxA, nim, ermG, ermF, bexA, bla, bla, bla, bla and bla. The presence of these genes was compared with phenotypic resistance to ampicillin/sulbactam, cefoxitin, ceftolozane/tazobactam, piperacillin/tazobactam, imipenem, meropenem, meropenem/vaborbactam, clindamycin, moxifloxacin, tigecycline, eravacycline and metronidazole.
tetQ was the most frequently detected gene, followed by cfiA, ermF, cfxA, ermG, cepA, nim and bexA. None of the strains were positive for tetM, tet36, bla, bla, bla, bla or bla. Resistance to the tested β-lactams was mainly linked to the presence of the cfiA gene. Clindamycin resistance correlated with the presence of the genes ermG and ermF. The bexA gene was found in six strains, but only two of them were resistant to moxifloxacin. Tigecycline and eravacycline showed good activities despite the frequent occurrence of tetQ. The nim gene was detected in six isolates, five of which were resistant to metronidazole.
The findings of our study support the general belief that antimicrobial resistance within Bacteroides should be taken into consideration. This underlines the necessity of reliable routine antimicrobial susceptibility test methods for anaerobic bacteria and the implementation of antimicrobial surveillance programmes worldwide.
拟杆菌属是人类肠道微生物群的正常组成部分,但它们也能够引起严重疾病。本研究旨在确定表型耐药拟杆菌属和副拟杆菌属菌株中发现的抗生素耐药基因的多样性。
从 71 份来自人类临床标本的表型耐药拟杆菌属中筛选 cfiA、tetQ、tetM、tet36、cepA、cfxA、nim、ermG、ermF、bexA、bla、bla、bla、bla 和 bla 抗生素耐药基因。将这些基因的存在与对氨苄西林/舒巴坦、头孢西丁、头孢他啶/他唑巴坦、哌拉西林/他唑巴坦、亚胺培南、美罗培南、美罗培南/沃诺拉赞、克林霉素、莫西沙星、替加环素、依拉环素和甲硝唑的表型耐药进行比较。
tetQ 是最常检测到的基因,其次是 cfiA、ermF、cfxA、ermG、cepA、nim 和 bexA。没有菌株对 tetM、tet36、bla、bla、bla、bla 或 bla 呈阳性。对所测试的β-内酰胺类药物的耐药性主要与 cfiA 基因的存在有关。克林霉素耐药与 ermG 和 ermF 基因的存在相关。bexA 基因在 6 株菌中发现,但只有 2 株对莫西沙星耐药。替加环素和依拉环素尽管经常出现 tetQ,但仍表现出良好的活性。nim 基因在 6 个分离株中被检测到,其中 5 个对甲硝唑耐药。
本研究的结果支持普遍认为的拟杆菌属内的抗菌药物耐药性应加以考虑的观点。这强调了在全球范围内需要可靠的常规抗菌药物敏感性测试方法来检测厌氧菌,并实施抗菌药物监测计划。